Effect of Pioglitazone on T2DM Patients With COVID-19
NCT04604223
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
1506
Enrollment
OTHER
Sponsor class
Conditions
Covid19
Type 2 Diabetes
Interventions
DRUG:
Pioglitazone 45 mg
Sponsor
Dasman Diabetes Institute
Collaborators
[object Object]
[object Object]
[object Object]